Skip to main content
Equibles

CASIF · CASI Pharmaceuticals, Inc. · Debt

Track CASIF — free

Use CASIF with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CASIF.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.12 +0.00 (+0.00%) At close · Oct 2
Rebalance outlook locked
Market Cap
$2.26M
Shares
20.56M
Volume · Oct 2 1025 Avg daily vol (3M) 2356

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current portion of long-term debt 2025-12-31 USD 19,190,000 20-F filed 2026-05-15
Operating lease liabilities 2025-12-31 USD 3,052,000 20-F filed 2026-05-15
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current operating lease liabilities
USD 1,611,000
Noncurrent operating lease liabilities
USD 1,441,000
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1962738 CUSIP G1933S101 Visit website Investor relations